Taking a page from an established Customs program, importers of active pharmaceutical ingredients (APIs) and finished drug products may now have the opportunity to become eligible for expedited entry into the United States. ...more
In this issue:
- It’s Easier Being Green
- Off-Label Marketing Protected by First Amendment
- Understanding New Restrictions on Advertising GI Bill Benefits
- FTC Looks at "The Big Picture"
On December 3, 2012, the United States Court of Appeals for the Second Circuit, in a 2-1 opinion, vacated the criminal conviction of a pharmaceutical sales representative for promoting off-label uses of a particular drug....more